ARCHIVES

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

This article is from The Cancer Letter archive.

Vol. 40 No. 03 | January 17, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: President’s Cancer Panel Issues Statement On National Cancer Program

September 17, 1999

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993

ECOG Phase III Trial To Test Hormones Vs. Chemotherapy For Prostate Cancer.

July 4, 2003

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 12, 1974

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999